Media & Communication

29k International AB is a Swedish non-profit tech foundation offering a free mental health app with science-based psychological tools and peer support programs, partnering with institutions including Karolinska Institute and Harvard University. The organization has been involved in clinical research as a digital therapeutic support platform in studies exploring mental health outcomes alongside psychedelic and other novel interventions.

Public-service international news organization with recurring coverage of psychedelic clinical evidence, regulation, and public-health implications.

Biopharma trade publication reporting on psychedelic clinical trial outcomes, approvals, setbacks, and market context.

UK-based organizer behind the Breaking Convention conference series focused on multidisciplinary psychedelic research, culture, and policy dialogue.

Psychedelic media publication covering education, culture, policy, and practical guidance around psychedelic use and integration.

Biopharma trade news outlet covering psychedelic biotech pipelines, financing, trial results, and regulatory milestones.

Biotechnology industry publication with recurring coverage of psychedelic drug-development programs and deal activity.

European biotech trade outlet with recurring coverage of psychedelic startups, R&D programs, and financing developments.

Online-first psychedelic journalism outlet focused on digital reporting, commentary, and analysis across science, policy, and culture.

Nonprofit organizer and host of the Psychedelic Science conference series, alongside broader educational and policy programming.

European nonprofit research and implementation organization that organizes the INSIGHT Conference and allied public/professional events.

Industry media and events platform that organizes psychedelic-focused conference programming and business-community convenings.

U.S. public media network with recurring psychedelic reporting across science, health, policy, and patient-outcome narratives.

Dutch nonprofit organizer in the psychedelic field, including stewardship of the ICPR conference series and related professional convenings.

Digital intelligence publication for psychedelic industry coverage, delivering online analysis, dashboards, and market-focused media content.

Trade publication and market-intelligence platform providing psychedelic industry news, analysis, company coverage, and investor-oriented reporting.

Independent psychedelic publication platform featuring long-form writing, commentary, and interdisciplinary perspectives on psychedelic culture and research.

Online psychedelic publication with digital media programming, including recurring video/news formats and multimedia coverage.

Digital-first psychedelic media platform publishing podcasts, video content, newsletters, and online storytelling for professional and public audiences.

Health and biotech trade publication with sustained reporting on psychedelic clinical development, regulation, and commercialization.

Mainstream international magazine with repeated long-form and news coverage on psychedelic medicine development and policy shifts.

Global general-news outlet with sustained reporting and commentary on psychedelic science, policy reform, safety, and cultural adoption.

Major U.S. news publication with ongoing reporting on psychedelic health research, therapeutic access, legal frameworks, and safety concerns.

Digital platform combining psychedelic education, media publishing, and multimedia content formats for consumer and practitioner audiences.

Digital-first global media brand with extensive psychedelic-focused journalism spanning science explainers, policy analysis, and culture reporting.

Adaptive digital music platform for psychedelic and consciousness-altering therapy contexts, enabling immersive, session-responsive media experiences.

Pharmaceutical industry publication that includes periodic coverage and commentary on psychedelic therapies and implementation challenges.